High dividend yields are typically achieved by investing in closed-end funds, real estate investment trusts, utility companies and royalty trusts, while pharmaceuticals and technology corporations, for example, usually pay only a modest dividend as they use most of their earnings to fund expansion. Yet, the pharmaceutical PDLI BioPharma maintains their dividend policy to yield 16.1%. Although this is largely due to the decreased share price resulting from continued revenue shrinkage, managements' refusal to cut dividends indicates their belief of prosperity in upcoming periods.
Source: Investopedia
Related Articles:
- Who is David Dodd and Why Should We Listen to Him
- Nucor Corp. (NUE): Forging A Different Path
- 4 Dividend Stocks For The Social Security Blues
- 8 Dividend Stocks Covering Their Dividend
- Is Your Portfolio Average?
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.